Relationship between concurrent substance abuse in psychiatric patients and neuroleptic dosage

American Journal of Drug and Alcohol Abuse

Volumn 21, Issue 2, 1995, Pages 257-265

  D'Mello, Dale A ^a   Boltz, Maryanne K ^b   Msibi, Bhekumusa ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b St Lawrence Hospital Lansing ^*  (United States)

^c MI   (United States)

Author keywords

Neuroleptic dosage; Psychiatric illness; Substance abuse

Indexed keywords

ALCOHOL; CANNABIS; CENTRAL STIMULANT AGENT; CHLORPROMAZINE; COCAINE; ILLICIT DRUG; NARCOTIC AGENT; NEUROLEPTIC AGENT; ORGANIC SOLVENT; PSYCHEDELIC AGENT; SEDATIVE AGENT;

ADULT; AKATHISIA; ALCOHOL ABUSE; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; PARKINSONISM; PATIENT COMPLIANCE; RATING SCALE; SCHIZOIDISM; SCHIZOPHRENIA; SUBSTANCE ABUSE; TARDIVE DYSKINESIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHLORPROMAZINE; COHORT STUDIES; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; HUMAN; MALE; MENTAL DISORDERS; MIDDLE AGE; NARCOTICS; SUBSTANCE-RELATED DISORDERS;

EID: 0028969633     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.3109/00952999509002693     Document Type: Article

References (31)

1. Prevalence of dual diagnoses of mental and substance abuse disorders in general hospitals
2. Alcohol use and abuse in schizophrenic prospective community study
3. Correlates of acting-out behaviors among young adult chronic patients
4. Medication compliance and substance abuse among schizophrenic patients
5. Cannabis affects the severity of schizophrenia symptoms: Results of a clinical survey
6. Substance abuse by young adult chronic patients
7. The new chronic patient and the system of community care
8. Psychotogenic drug use and neuroleptic response
9. Drug abuse in schizophrenic patients: Clinical correlates and reasons for use
10. The Brief Psychiatric Rating Scale
11. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia
12. A comparison of equivalent clinical potencies of neuroleptics as used to treat schizophrenia and affective disorders
13. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences
14. Cannabis and schizophrenia: A longitudinal study of Swedish conscripts
15. Features of Cocaine-Induced Paranoia
16. Cocaine-induced psychosis
17. Pharmacology of cocaine
18. Cocaine and other stimulants
19. The brain NMDA receptor, psychotomimetic drug effects, and schizophrenia
20. The effects of long-term ethanol on brain receptors for dopamine, acetylcholine, serotonin and noradrenaline
21. Alcohol and disease: Central nervous system
22. Forty-six cases of psychosis in cannabis users
23. Suspiciousness induced by four-hour intravenous infusions of cocaine. Preliminary findings
24. Amphetamine psychosis: A “model” schizophrenia mediated by catecholamines
25. Drug history in tardive dyskinesia
26. Assessment of tardive dyskinesia in psychiatric outpatients using a standardized rating scale
27. Tardive dyskinesia and the primary psychiatric diagnosis
28. Tardive dyskinesia in psychiatric patients with substance use disorders
29. Increased tardive dyskinesia in alcohol-abusing schizophrenic patients
30. Tardive dyskinesia: Prevalence and risk factors, 1959 to 1979
31. The effect of drug holidays in an animal model of tardive dyskinesia